By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Dr. Reddy's Laboratories Ltd. 

7-1-27 Ameerpet

Hyderabad  Andhra Pradesh  500016  India
Phone: 91-40-23731946 Fax: 91-40-23731955


SEARCH JOBS


Industry
Pharmaceutical






Company News
Dr. Reddy's Laboratories Ltd. (RDY) To Release Q4 And Full Year FY16 Results On May 12, 2016; Earnings Call Slated For May 12, 6.30 PM IST / 9.00 AM EDT 4/26/2016 12:48:00 PM
CutisPharma, Dr. Reddy's Laboratories Ltd. (RDY) Announce Partnership 4/5/2016 6:02:48 AM
Dr. Reddy's Laboratories Ltd. (RDY) Inks Licensing Pact with Japan's Eisai Company (ESALY.PK) for Anti-Cancer Agent 3/31/2016 6:08:26 AM
Bay Area's XenoPort (XNPT) Snags Psoriasis and MS Deal Worth $490 Million+ from Dr. Reddy's Laboratories Ltd. (RDY) 3/28/2016 6:01:55 AM
Dr. Reddy's Laboratories Ltd. (RDY) And TRPharm Announce Strategic Collaboration In Turkey 3/11/2016 9:39:13 AM
Dr. Reddy's Laboratories Ltd. (RDY)’s ("Company") Board Approves The Proposal For Buyback Of Its Equity Shares 2/18/2016 10:03:41 AM
Dr. Reddy's Laboratories Ltd. (RDY)’s Q3 And 9M FY16 Financial Results 2/9/2016 9:52:45 AM
Dr. Reddy's Laboratories Ltd. (RDY) Receives FDA Approval For ZEMBRACE Symtouch (sumatriptan succinate) Injection For The Acute Treatment Of Migraines In Adults 2/3/2016 6:00:58 AM
Dr. Reddy's Laboratories Ltd. (RDY) Receives FDA Tentative Approval For Zenavod (Doxycycline) Capsules, 40 Mg For The Treatment Of Rosacea In Adults 2/1/2016 11:30:55 AM
Dr. Reddy's Laboratories Ltd. (RDY) Receives FDA Approval For ZEMBRACE Symtouch (Sumatriptan Succinate) Injection For The Acute Treatment Of Migraines In Adults 1/29/2016 9:22:08 AM
12345678910...
//-->